Home
AVDL
AVDL News

Latest Avadel Pharmaceuticals plc (AVDL) News on October 16, 2025

Analysts Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Breakeven Soon

Simply Wall St.

11 days ago

Analysts Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Breakeven Soon

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High?

Zacks

4 months ago

Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High?

Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock

Zacks

4 months ago

Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock

Following a 34% decline over last year, recent gains may please Avadel Pharmaceuticals plc (NASDAQ:AVDL) institutional owners

Simply Wall St.

4 months ago

Following a 34% decline over last year, recent gains may please Avadel Pharmaceuticals plc (NASDAQ:AVDL) institutional owners

MT Newswires

4 months ago

Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday

MT Newswires

4 months ago

Avadel Pharmaceuticals Gets Orphan Drug Designation for Lumryz to Treat Idiopathic Hypersomnia

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

GlobeNewswire

4 months ago

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025

Insider Monkey

5 months ago

Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025

GlobeNewswire

5 months ago

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025

Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet

Zacks

5 months ago

Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet

Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

5 months ago

Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy

Zacks

5 months ago

All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy

MT Newswires

5 months ago

Avadel Pharmaceuticals Names Chief Operating Officer

Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

GlobeNewswire

5 months ago

Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

GlobeNewswire

5 months ago

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy?

Zacks

5 months ago

Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy?

Wall Street Analysts Believe Avadel (AVDL) Could Rally 100.21%: Here's is How to Trade

Zacks

5 months ago

Wall Street Analysts Believe Avadel (AVDL) Could Rally 100.21%: Here's is How to Trade

Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results

Simply Wall St.

5 months ago

Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Avadel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

MT Newswires

5 months ago

Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $16 From $13, Maintains Buy Rating

GuruFocus.com

5 months ago

Avadel Pharmaceuticals PLC (AVDL) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...

Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight

TipRanks

5 months ago

Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight

Associated Press Finance

5 months ago

Avadel: Q1 Earnings Snapshot

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance

GlobeNewswire

5 months ago

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance

MT Newswires

5 months ago

Avadel Says Court Grants Favorable Ruling in Appeal of Delaware Injunction on Lumryz

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

GlobeNewswire

5 months ago

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

GlobeNewswire

6 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

MT Newswires

6 months ago

UBS Adjusts Avadel Pharmaceuticals Price Target to $12 From $14, Maintains Buy Rating

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

GlobeNewswire

6 months ago

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability

Simply Wall St.

6 months ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

6 months ago

Avadel Pharmaceuticals Projects 'Sustainable' Positive Cash Flow in 2025

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

GlobeNewswire

6 months ago

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

GlobeNewswire

7 months ago

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 03/10/2025

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 03/07/2025

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 03/06/2025

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

7 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 03/05/2025

MT Newswires

7 months ago

Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 03/04/2025

Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

7 months ago

Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

GuruFocus.com

7 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Associated Press Finance

7 months ago

Avadel: Q4 Earnings Snapshot

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

7 months ago

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 03/03/2025

Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey

8 months ago

Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?

GuruFocus.com

8 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Look For

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/28/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/27/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/26/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/25/2025

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3

GlobeNewswire

8 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

GlobeNewswire

8 months ago

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/24/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/21/2025

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/20/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/19/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/18/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/14/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/13/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/12/2025

MT Newswires

8 months ago

Deutsche Bank Initiates Coverage on Avadel Pharmaceuticals With Buy Rating, $12 Price Target

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/11/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/10/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/07/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/06/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/05/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/04/2025

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 02/03/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/31/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/30/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/29/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/28/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/27/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/24/2025

Argus Research

9 months ago

Daily – Vickers Top Buyers & Sellers for 01/23/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/23/2025

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement

GlobeNewswire

9 months ago

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/22/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/21/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/17/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/16/2025

Argus Research

9 months ago

Daily – Vickers Top Insider Picks for 01/15/2025

Argus Research

9 months ago

Daily – Vickers Top Buyers & Sellers for 01/15/2025

MT Newswires

9 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $14 From $22, Maintains Buy Rating

MT Newswires

9 months ago

Needham Adjusts Avadel Pharmaceuticals' Price Target to $19 From $22, Keeps Buy Rating

GuruFocus.com

9 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

MT Newswires

9 months ago

Avadel Pharmaceuticals Preliminary Q4 Net Product Revenue Rises; 2025 Outlook Set; Shares Fall After Hours

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

GlobeNewswire

9 months ago

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

9 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

GlobeNewswire

9 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock

Simply Wall St.

10 months ago

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

GlobeNewswire

10 months ago

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

Share on Social Networks: